BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1061 related articles for article (PubMed ID: 16038636)

  • 21. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
    Fu L; Liang Y; Deng L; Ding Y; Chen L; Ye Y; Yang X; Pan Q
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibitory effects of celecoxib combined with octreotide on growth of multidrug resistant human gastric cancer cell line SGC7901/ADR].
    Zheng WB; Wang CH; Qiang O; Tang CW
    Ai Zheng; 2004 Dec; 23(12):1628-32. PubMed ID: 15601550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR by LY980503.
    Wu DL; Xu Y; Yin LX; Lu HZ
    World J Gastroenterol; 2007 Apr; 13(15):2234-7. PubMed ID: 17465508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone.
    Li DQ; Wang ZB; Bai J; Zhao J; Wang Y; Hu K; Du YH
    World J Gastroenterol; 2004 Jun; 10(12):1722-5. PubMed ID: 15188493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of multidrug resistance of vincristine-resistant gastric adenocarcinoma cells through up-regulation of DARPP-32.
    Hong L; Wang J; Han Y; Zhao Y; Gao J; Wang J; Han Y; Zhang X; Yan L; Zhou X; Qiao T; Chen Z; Fan D
    Cell Biol Int; 2007 Sep; 31(9):1010-5. PubMed ID: 17470401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cationic submicron emulsions overcome multidrug resistance in SGC7901/VCR cells.
    Zhao YX; Liang WQ; Wang Y; Liu DX
    Pharmazie; 2011 Feb; 66(2):130-5. PubMed ID: 21434576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reversal of multidrug resistance of the drug resistant human multiple myeloma cell line MOLP-2/R by curcumin and its relation with FA/BRCA pathway].
    Xiao H; Zhang KJ; Zuo XL
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):33-7. PubMed ID: 19563033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosiglitazone reverses mitomycin C resistance in human gastric cancer cells.
    Zhang L; Hu JF; Li GQ; Xiao X; Su Q
    Am J Med Sci; 2012 May; 343(5):382-7. PubMed ID: 22052411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levistolide A overcomes P-glycoprotein-mediated drug resistance in human breast carcinoma cells.
    Chen F; Wang T; Wang J; Wang ZQ; Qian M
    Acta Pharmacol Sin; 2008 Apr; 29(4):458-64. PubMed ID: 18358092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity.
    Xi GM; Sun B; Jiang HH; Kong F; Yuan HQ; Lou HX
    Bioorg Med Chem; 2010 Sep; 18(18):6725-33. PubMed ID: 20724170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line.
    Yang YX; Chen ZC; Zhang GY; Yi H; Xiao ZQ
    J Cell Biochem; 2008 Jun; 104(3):1010-21. PubMed ID: 18253933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RhoE enhances multidrug resistance of gastric cancer cells by suppressing Bax.
    Li K; Lu Y; Liang J; Luo G; Ren G; Wang X; Fan D
    Biochem Biophys Res Commun; 2009 Feb; 379(2):212-6. PubMed ID: 19101510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sorcin overexpression and multidrug resistance in human gastric cancer cells].
    Yi H; Yang YX; Tang CE; Chen ZC; Zhang GY; Xiao ZQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):340-4, 349. PubMed ID: 16859119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of TRAIL on the expression of multidrug resistant genes MDR1, LRP and GST-π in drug-resistant gastric cancer cell SGC7901/VCR.
    Zhang KG; Qin CY; Wang HQ; Wang JX; Wang QM
    Hepatogastroenterology; 2012; 59(120):2672-6. PubMed ID: 23178631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of parthenolide on proliferation and apoptosis in gastric cancer cell line SGC7901.
    Zhao LJ; Xu YH; Li Y
    J Dig Dis; 2009 Aug; 10(3):172-80. PubMed ID: 19659784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
    Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P
    In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.
    Holland ML; Panetta JA; Hoskins JM; Bebawy M; Roufogalis BD; Allen JD; Arnold JC
    Biochem Pharmacol; 2006 Apr; 71(8):1146-54. PubMed ID: 16458258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.